Background & Aims Although approximately 40% of patients with nonalcoholic fatty liver
disease (NAFLD) are nonobese or lean, little is known about the long-term clinical outcomes …

Non‐alcoholic fatty liver disease (NAFLD) is one of the most common causes of hepatic
disorders. It represents a wide range of chronic liver diseases in patients with no history of …

Abstract Background & Aims How adiposity influences the effect of genetic variants on non‐
alcoholic fatty liver disease (NAFLD) in the Asian population remains unclear. We aimed to …

Aim Coronavirus disease 2019 (COVID-19) is a recently encountered disease that was
declared a pandemic by WHO in 2020. Obesity and other components of the metabolic …

Abstract Background & Aims Obesity and non‐alcoholic fatty liver disease (NAFLD) are
known risk factors for gastrointestinal (GI) cancers. However, GI carcinogenesis in lean …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, with
an estimated prevalence of 25% globally. NAFLD is closely associated with metabolic …

Methods From January 2009 to December 2019, 175 patients with histology-proven hepatic
steatosis and 10 with cryptogenic cirrhosis who were treated at National Taiwan University …

Non-alcoholic fatty liver disease (NAFLD), which approximately affects a quarter of the
world's population, has become a major public health concern. Although usually associated …

Summary Background Non-Alcoholic Fatty Liver Disease (NAFLD) is defined as increased
liver fat percentage, and is the most common chronic liver disease in children. Rather than …

Diabetes mellitus (DM) is common in liver cirrhosis (LC). The pathophysiological association
is bidirectional. DM is a risk factor of LC and LC is a diabetogenic condition. In the recent …